Regeneron Pharmaceuticals, Inc. Current Ratio for the Trailing 12 Months (TTM) ending March 31, 2025: 5.08

Regeneron Pharmaceuticals, Inc. Current Ratio is 5.08 for the Trailing 12 Months (TTM) ending March 31, 2025, a -5.70% change year over year. Current ratio represents the short-term liquidity measurement, showing current assets' coverage of liabilities. Higher ratio implies better ability to meet short-term obligations.
  • Regeneron Pharmaceuticals, Inc. Current Ratio for the Trailing 12 Months (TTM) ending March 31, 2024 was 5.39, a 2.24% change year over year.
  • Regeneron Pharmaceuticals, Inc. Current Ratio for the Trailing 12 Months (TTM) ending March 31, 2023 was 5.27, a 18.40% change year over year.
  • Regeneron Pharmaceuticals, Inc. Current Ratio for the Trailing 12 Months (TTM) ending March 31, 2022 was 4.45, a 35.14% change year over year.
  • Regeneron Pharmaceuticals, Inc. Current Ratio for the Trailing 12 Months (TTM) ending March 31, 2021 was 3.30, a -26.76% change year over year.
Key Data
Date Current Ratio Interest Coverage Ratio Return on Capital Employed (ROCE) Return on Equity (ROE)